Literature DB >> 1559588

Decrease in haematocrit with continuous positive airway pressure treatment in obstructive sleep apnoea patients.

J Krieger1, E Sforza, C Delanoe, C Petiau.   

Abstract

Previous preliminary results have shown an overnight decrease in haematocrit and red cell count after the first night of treatment with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA) patients. The present study was designed to confirm these preliminary data, and to analyse the long-term effects of CPAP. The haematocrit and red cell count (RCC) were measured in 80 OSA patients on two consecutive mornings, after an untreated night and after a CPAP treatment night. The haematocrit and RCC significantly decreased with CPAP (from 44.0 +/- 0.5 to 42.4 +/- 0.4%, p less than 0.0001 and from 4.769 +/- 0.051 to 4.597 +/- 0.052 x 10(12) red cells.l-1, p less than 0.0001, respectively). Neither the decrease in haematocrit nor the decrease in RCC were correlated with the decrease in urine volume or flow which occurred with CPAP. Thirty five of these patients remained untreated for 45 +/- 4 days, before home treatment with CPAP was initiated. The haematocrit and RCC had returned to values close to those before initial treatment and decreased again after the first treatment night. Twenty one of the patients were re-evaluated after at least one year of home treatment with CPAP, again on two consecutive nights either with CPAP or untreated. The follow-up, post-CPAP haematocrit and RCC were slightly and nonsignificantly higher than after the baseline CPAP night, but still lower than after the baseline untreated night (p less than 0.02). After the untreated follow-up night, no significant change in haematocrit was observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1559588

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

Review 1.  Coagulability in obstructive sleep apnea.

Authors:  Christina Liak; M Fitzpatrick
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

2.  Sex-specific associations between erythrocyte measures and obstructive sleep apnea.

Authors:  Taomei Li; Naima Covassin; Lu Tan; Rong Ren; Ye Zhang; Fei Lei; Linghui Yang; Junying Zhou; Hongqiang Sun; Virend K Somers; Xiangdong Tang
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

3.  Does obstructive sleep apnea increase hematocrit?

Authors:  Jong Bae Choi; José S Loredo; Daniel Norman; Paul J Mills; Sonia Ancoli-Israel; Michael G Ziegler; Joel E Dimsdale
Journal:  Sleep Breath       Date:  2006-09       Impact factor: 2.816

Review 4.  Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure.

Authors:  Domenico Maurizio Toraldo; Michele De Benedetto; Egeria Scoditti; Francesco De Nuccio
Journal:  Sleep Breath       Date:  2015-07-14       Impact factor: 2.816

5.  Sleep apnea is associated with cardiovascular risk factors among kidney transplant patients.

Authors:  Miklos Zsolt Molnar; Alpar Sandor Lazar; Anett Lindner; Katalin Fornadi; Maria Eszter Czira; Andrea Dunai; Rezso Zoller; Andras Szentkiralyi; Laszlo Rosivall; Colin Michael Shapiro; Marta Novak; Istvan Mucsi
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 8.237

Review 6.  Sleep-related breathing disorders. 4. Consequences of sleep disordered breathing.

Authors:  K A Ferguson; J A Fleetham
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

7.  Redox-Oligomeric State of Peroxiredoxin-2 and Glyceraldehyde-3-Phosphate Dehydrogenase in Obstructive Sleep Apnea Red Blood Cells under Positive Airway Pressure Therapy.

Authors:  Cristina Valentim-Coelho; Fátima Vaz; Marília Antunes; Sofia Neves; Inês L Martins; Hugo Osório; Amélia Feliciano; Paula Pinto; Cristina Bárbara; Deborah Penque
Journal:  Antioxidants (Basel)       Date:  2020-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.